Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device

  • Kevin Chung

Press/Media

Period31 Oct 2023

Media coverage

9

Media coverage

  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletMorningstar.com
    Country/TerritoryUnited States
    Date31/10/23
    URLct.moreover.com/?a=52207671870&p=1gw&v=1&x=veQ4yJPoejlr4JDbeHU8vw
    PersonsKevin Chung
  • TitleNuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter For Its Pediatric Selective Cytopheretic Device
    Media name/outletBENZINGA Newswire
    Country/TerritoryUnited States
    Date31/10/23
    PersonsKevin Chung
  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletStreet Insider
    Country/TerritoryUnited States
    Date31/10/23
    URLct.moreover.com/?a=52207547388&p=1gw&v=1&x=mcBDwwCIsOKMtC4Y4xPHBQ
    PersonsKevin Chung
  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletADVFN UK
    Country/TerritoryUnited Kingdom
    Date31/10/23
    URLct.moreover.com/?a=52207620220&p=1gw&v=1&x=Kk2DPPe9Bpcp1Uj9DxzWHg
    PersonsKevin Chung
  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletYahoo! Finance
    Country/TerritoryUnited States
    Date31/10/23
    URLct.moreover.com/?a=52207626742&p=1gw&v=1&x=KJVWDxPx1ny7_p63PSr95A
    PersonsKevin Chung
  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletADVFN US
    Country/TerritoryUnited States
    Date31/10/23
    URLct.moreover.com/?a=52207562231&p=1gw&v=1&x=x1GZEyQ1W-ASS16iqBJeaQ
    PersonsKevin Chung
  • TitleNuwellis Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date31/10/23
    PersonsKevin Chung
  • TitleNuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletGlobeNewswire
    Country/TerritoryUnited States
    Date31/10/23
    URLct.moreover.com/?a=52207610749&p=1gw&v=1&x=1xWl_9wJEoMjmECbSi5OeA
    PersonsKevin Chung
  • TitleNuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
    Media name/outletBizWire Express
    Country/TerritoryIndia
    Date31/10/23
    URLct.moreover.com/?a=52207827335&p=1gw&v=1&x=4zJqFs1-_kERFHMZCj8ktQ
    PersonsKevin Chung